Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07638241 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Agentic AI Personalized Dietary Management Study

Study acronym: AIDiet
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Sep 10, 2026 → Feb 26, 2027
See other at-risk trials from Seoul National University Hospital

Record History

  1. Notable Recruitment opened Primary completion pushed from Sep 10, 2026 to Feb 26, 2027 · Study sites: 0 to 1 · Start date changed from estimate of Jun 8, 2026 to Jun 11, 2026 · 3 more Show 6 more changesShow less
    • Primary completion pushed from Sep 10, 2026 to Feb 26, 2027
    • Study sites: 0 to 1
    • Start date changed from estimate of Jun 8, 2026 to Jun 11, 2026
    • Eligibility criteria expanded, about 14 words
    • Secondary endpoints: details revised at 13 of 17 entries
    • Collaborator revised
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This randomized controlled trial aims to evaluate the effectiveness of an Agentic AI-based personalized dietary management algorithm among adults undergoing health screening. Participants will be assigned to a control group, a static goal AI intervention group, or an adaptive goal AI intervention group and followed for 12 weeks.
Trial Details
NCT Number NCT07638241
Lead Sponsor Seoul National University Hospital
Collaborators: Ministry of Agriculture, Food and Rural Affairs
Conditions Dietary Behavior; Metabolic Health; Obesity; Lifestyle Modification; Metabolic Syndrome Risk
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov